BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11327243)

  • 1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
    Kaltenhäuser S; Wagner U; Schuster E; Wassmuth R; Arnold S; Seidel W; Tröltzsch M; Loeffler M; Häntzschel H
    J Rheumatol; 2001 Apr; 28(4):735-44. PubMed ID: 11327243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between body mass index and radiological progression in patients with rheumatoid arthritis.
    Kaufmann J; Kielstein V; Kilian S; Stein G; Hein G
    J Rheumatol; 2003 Nov; 30(11):2350-5. PubMed ID: 14677176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.
    Kaltenhäuser S; Pierer M; Arnold S; Kamprad M; Baerwald C; Häntzschel H; Wagner U
    Rheumatology (Oxford); 2007 Jan; 46(1):100-4. PubMed ID: 16728439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of HLA-DRB1 shared epitope, -308 tumor necrosis factor-alpha gene promoter polymorphism, rheumatoid factor, anti-citrullinated peptide antibodies, and early erosions for predicting radiological outcome in recent-onset rheumatoid arthritis.
    Reneses S; González-Escribano MF; Fernández-Suárez A; Pestana L; Davila B; Wichmann I; García A
    J Rheumatol; 2009 Jun; 36(6):1143-9. PubMed ID: 19411391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of the HLA shared epitope for severity of radiological joint damage in patients with rheumatoid arthritis. A 10 year observational prospective study.
    Valenzuela-Castaño A; García-López A; Pérez-Vilches D; Rodriguez-Pérez R; Gonzalez-Escribano MF; Núñez-Roldán A
    J Rheumatol; 2000 Mar; 27(3):571-4. PubMed ID: 10743791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis.
    Wagner U; Kaltenhäuser S; Sauer H; Arnold S; Seidel W; Häntzschel H; Kalden JR; Wassmuth R
    Arthritis Rheum; 1997 Feb; 40(2):341-51. PubMed ID: 9041946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.
    Graudal N
    Scand J Rheumatol Suppl; 2004; 118():1-38. PubMed ID: 15180092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study.
    Suarez-Almazor ME; Tao S; Moustarah F; Russell AS; Maksymowych W
    J Rheumatol; 1995 Nov; 22(11):2027-33. PubMed ID: 8596139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.
    Mattey DL; Hassell AB; Dawes PT; Cheung NT; Poulton KV; Thomson W; Hajeer AH; Ollier WE
    Arthritis Rheum; 2001 Jul; 44(7):1529-33. PubMed ID: 11465703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of the HLA-DRB1 shared epitope for predicting radiographic damage in rheumatoid arthritis depends on the individual patient risk profile.
    Janssens AC; Steyerberg EW; Jiang Y; Habbema JD; Van Duijn CM; Criswell LA
    J Rheumatol; 2006 Dec; 33(12):2383-9. PubMed ID: 16960929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis.
    Shadick NA; Heller JE; Weinblatt ME; Maher NE; Cui J; Ginsburg G; Coblyn J; Anderson R; Solomon DH; Roubenoff R; Parker A
    Ann Rheum Dis; 2007 Nov; 66(11):1497-502. PubMed ID: 17491100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.
    Mewar D; Coote A; Moore DJ; Marinou I; Keyworth J; Dickson MC; Montgomery DS; Binks MH; Wilson AG
    Arthritis Res Ther; 2006; 8(4):R128. PubMed ID: 16859535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis.
    Morel J; Roch-Bras F; Molinari N; Sany J; Eliaou JF; Combe B
    Ann Rheum Dis; 2004 Dec; 63(12):1581-6. PubMed ID: 15547082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study.
    Stockman A; Tait BD; Wolfe R; Brand CA; Rowley MJ; Varney MD; Buchbinder R; Muirden KD
    Rheumatol Int; 2006 Apr; 26(6):500-9. PubMed ID: 16151812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.